Abstract Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is the causative
agent of the pandemic disease COVID-19, which is so far without efficacious treatment. The …

Background Lung diseases including chronic obstructive pulmonary disease (COPD),
infections like influenza, acute respiratory distress syndrome (ARDS), asthma and …

Abstract Since December 2019 the Severe Acute Respiratory Syndrome Coronavirus 2
(SARS-CoV-2) has produced an outbreak of pulmonary disease which has soon become a …

Abstract COVID-19 (Coronavirus disease 2019) is a transmissible disease initiated and
propagated through a new virus strain SARS-CoV-2 (Severe Acute Respiratory Syndrome …

Drug repurposing involves the identification of new applications for existing drugs at a lower
cost and in a shorter time. There are different computational drug-repurposing strategies and …

A novel coronavirus responsible of acute respiratory infection closely related to SARS-CoV
has recently emerged. So far there is no consensus for drug treatment to stop the spread of …

The COVID-19 caused by the SARS-CoV-2 virus was declared a pandemic disease in
March 2020 by the World Health Organization (WHO). Structure-Based Drug Design …

The receptor‐binding domain (RBD) of the severe acute respiratory syndrome coronavirus 2
spike (S) protein plays a central role in mediating the first step of virus infection to cause …

Objective: To evaluate different doses of ivermectin in adult patients with mild COVID-19 and
to evaluate the effect of ivermectin on mortality and clinical consequences. Methods: A …

The situation of coronavirus disease 2019 (COVID‐19) pandemic is rapidly evolving, and
medical researchers around the globe are dedicated to finding cures for the disease. Drug …